Chargement en cours...
Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis
BACKGROUND AND PURPOSE: The considerable clinical effect of natalizumab in patients with relapsing-remitting multiple sclerosis might be explained by its possible beneficial effect on axonal functioning. In this longitudinal study, the effect of natalizumab on absolute concentrations of total N-acet...
Enregistré dans:
| Publié dans: | AJNR Am J Neuroradiol |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Neuroradiology
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8013024/ https://ncbi.nlm.nih.gov/pubmed/25742985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A4252 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|